Evidence map›Paper›PMID 28856268›Full record

ArticleClinical and experimental hepatology2016

Liver transplantation in Central Europe.

Pavel Trunecka, Zsuzsanna Gerlei, Wojciech Lisik, Lubomir Skladany, Jiri Fronek, Stefan Hrusovsky, Piotr Małkowski

Open access · diamondAbstract read
In one paragraph

Article in Clinical and experimental hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Pavel TruneckaInstitute for Clinical and Experimental Medicine, Prague, Czech Republic.
Zsuzsanna GerleiSemmelweis University Transplantation and Surgical Clinic, Budapest, Hungary.
Wojciech LisikDepartment of General Surgery and Transplantology, Transplantation Institute, Medical University of Warsaw, Poland.
Lubomir SkladanyHEGITO - Department of Hepatology, Gastroenterology and Liver Transplantation of F. D. Roosevelt University Hospital, Banska Bystrica, Slovakia.
Jiri FronekInstitute for Clinical and Experimental Medicine, Prague, Czech Republic.
Stefan HrusovskyDepartment of Internal Medicine I of SMU, Derer University Hospital, Bratislava, Slovakia.
Piotr MałkowskiDepartment of General Surgery and Transplantology, Transplantation Institute, Medical University of Warsaw, Poland.
Institute of Clinical and Experimental Medicine · CZMedical University of Warsaw · PLSemmelweis University · HUUniversity Hospital Bratislava · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTransplant hepatologists convened in Warsaw on 20-21 November 2015 at a meeting of the Initiative Group for Central European Hepatologic Collaboration to exchange their experience in liver transplantation in their respective countries. MATERIAL AND

methodsThe description is based on narration of individual country representatives, supplemented by data from additional queries, and from publicly accessible sources.

resultsLiver transplantation programs were launched, in the Czech Republic in 1983, in Poland in 1990 (paediatric) followed by the adult program 1994; the first liver transplant in Hungary was performed in 1995, with Slovakia launching its liver transplantation program in 2008. Currently, there are 2 centres for liver transplantation in Slovakia, 1 centre in Hungary, 6 centres in Poland, and 2 centres in the Czech Republic. The rates of liver transplantation correspond to the number of cadaveric donations being the highest in the Czech Republic (15.8 per million population) and the lowest in Slovakia (4.2 per million population) (2014 data). Live donation is utilized systematically in Poland. Indications vary from country to country, but the 3 most frequent ones include hepatitis C and B cirrhosis, alcoholic cirrhosis, and cholestatic liver disorders. There is a growing incidence of hepatocellular carcinoma among adult liver transplant recipients. Biliary atresia and hereditary diseases are the most frequent indications among children. Hungary became a member of Eurotransplant, other countries are not a part of any international organization for organ sharing.

conclusionsDespite some differences, liver transplant programs seem to be compatible honouring the same values and principles universal to liver transplant programs in most parts of the world.

Indexed as

Central Hepatologic Collaborationliver transplantationorgan donationVisegrád Four

Identifiers

PMID28856268
PMCPMC5497409
OpenAlexW2404789447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.